| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/INFDIS/163.6.1247 |
| P698 | PubMed publication ID | 1903799 |
| P2093 | author name string | Tello A | |
| Ruiz J | |||
| Neeser JR | |||
| Cravioto A | |||
| Villafán H | |||
| del Vedovo S | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | enteropathogen | Q63500873 |
| oligosaccharide | Q320607 | ||
| Escherichia coli | Q25419 | ||
| Enteropathogenic Escherichia coli | Q13419512 | ||
| P1104 | number of pages | 9 | |
| P304 | page(s) | 1247-1255 | |
| P577 | publication date | 1991-06-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Inhibition of localized adhesion of enteropathogenic Escherichia coli to HEp-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk | |
| P478 | volume | 163 |
| Q51171028 | A new generation of carbohydrate-based therapeutics: recombinant mucin-type fusion proteins as versatile inhibitors of protein-carbohydrate interactions. |
| Q37260988 | Adherence, anti-adherence, and oligosaccharides preventing pathogens from sticking to the host |
| Q40685945 | Adhesion and its role in the virulence of enteropathogenic Escherichia coli |
| Q37651476 | Adhesion of Diarrheagenic Escherichia coli and Inhibition by Glycocompounds Engaged in the Mucosal Innate Immunity |
| Q35142691 | Adhesion of enteropathogenic Escherichia coli to host cells. |
| Q35576146 | Advances in the modulation of the microbial ecology of the gut in early infancy |
| Q35548772 | Anti-adhesion therapy of bacterial diseases: prospects and problems |
| Q35923378 | Antibody responses to Escherichia coli O157 and other lipopolysaccharides in healthy children and adults. |
| Q33598405 | Antigen detection in enteropathogenic Escherichia coli using secretory immunoglobulin A antibodies isolated from human breast milk |
| Q40598555 | Antimicrobial factors and microbial contaminants in human milk: recent studies |
| Q34064916 | Bacterial-epithelial contact is a key determinant of host innate immune responses to enteropathogenic and enteroaggregative Escherichia coli. |
| Q33910800 | Binding of Clostridium difficile toxins to human milk oligosaccharides. |
| Q35557671 | Binding of diarrheagenic Escherichia coli to 32- to 33-kilodalton human intestinal brush border proteins. |
| Q38356478 | Binding of milk oligosaccharides by several enterotoxigenic Escherichia coli strains isolated from calves |
| Q45958104 | Bioactive proteins in breast milk. |
| Q40716438 | Biological functions of oligosaccharides in human milk |
| Q43572311 | Blocking of Pseudomonas aeruginosa lectins by human milk glycans |
| Q33682806 | Breast milk and Group B streptococcal infection: vector of transmission or vehicle for protection? |
| Q77804200 | Breastfeeding provides passive and likely long-lasting active immunity |
| Q46679688 | Carbohydrate phenotyping of human and animal milk glycoproteins |
| Q36027779 | Clinical applications of bioactive milk components |
| Q55897103 | Colostrum and its benefits: a review |
| Q81019435 | Comparison of the antimicrobial adhesion potential of human body fluid glycoconjugates using fucose-binding lectin (PA-IIL) of Pseudomonas aeruginosa and Ulex europaeus lectin (UEA-I) |
| Q33556097 | Consumption of human milk oligosaccharides by gut-related microbes |
| Q56762900 | Coproantibodies to the enteropathogenic Escherichia coli vaccine candidates BfpA and EspB in breastfed and artificially fed children |
| Q35075768 | Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model |
| Q37642657 | Cytotoxicity, phytochemical analysis and antioxidant activity of crude extracts from rhizomes of Elephantorrhiza elephantina and Pentanisia prunelloides |
| Q34002734 | Decreased adherence of enterohemorrhagic Escherichia coli to HEp-2 cells in the presence of antibodies that recognize the C-terminal region of intimin |
| Q41928379 | Development of a live oral attaching and effacing Escherichia coli vaccine candidate using Vibrio cholerae CVD 103-HgR as antigen vector. |
| Q24533466 | Diarrheagenic Escherichia coli |
| Q37915055 | Early life: gut microbiota and immune development in infancy. |
| Q34905662 | Effect of molecules secreted by Lactobacillus acidophilus strain La-5 on Escherichia coli O157:H7 colonization |
| Q33747257 | Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge |
| Q35381252 | Enteropathogenic Escherichia coli. |
| Q63321268 | Evolution of milk oligosaccharides and lactose: a hypothesis |
| Q102062623 | Factors associated with typical enteropathogenic Escherichia coli infection among children <5 years old with moderate-to-severe diarrhoea in rural western Kenya, 2008-2012 |
| Q72302614 | Factors in human milk that protect against diarrheal disease |
| Q37284880 | From alpha to beta: identification of amino acids required for the N-acetyllactosamine-specific lectin-like activity of bundlin. |
| Q43653288 | Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation |
| Q34351355 | Glycan mimicry as a basis for novel anti-infective drugs |
| Q46273400 | Glycomacropeptide Reduces Intestinal Epithelial Cell Barrier Dysfunction and Adhesion of Entero-Hemorrhagic and Entero-Pathogenic Escherichia coli in Vitro |
| Q40832219 | Growth, development and differentiation: a functional food science approach |
| Q40839038 | Helicobacter pylori infection in patients with selective immunoglobulin a deficiency |
| Q34275923 | Human Milk Secretory Antibodies against Attaching and EffacingEscherichia coliAntigens |
| Q50075579 | Human milk glycoproteins inhibit the adherence of Salmonella typhimurium to HeLa cells |
| Q50083560 | Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris |
| Q43915683 | Human milk oligosaccharides: an enzymatic protection step simplifies the synthesis of 3'- and 6'-O-sialyllactose and their analogues |
| Q35534259 | Identification of a family of intimins common to Escherichia coli causing attaching-effacing lesions in rabbits, humans, and swine |
| Q39336218 | Identification of key proteins of cultured human intestinal cells involved in interaction with enteroaggregative Escherichia coli. |
| Q44007540 | Immune responses in rhesus rotavirus-challenged BALB/c mice treated with bifidobacteria and prebiotic supplements |
| Q36389762 | Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes |
| Q35530236 | Immunization of mice with Lactobacillus casei expressing a beta-intimin fragment reduces intestinal colonization by Citrobacter rodentium |
| Q36504030 | Immunoglobulin A antibodies directed against Campylobacter jejuni flagellin present in breast-milk |
| Q38341782 | Immunology and vaccines and nanovaccines for Helicobacter pylori infection |
| Q35665369 | Impact of human milk bacteria and oligosaccharides on neonatal gut microbiota establishment and gut health |
| Q24803073 | In vitro adhesion and invasion inhibition of Shigella dysenteriae, Shigella flexneri and Shigella sonnei clinical strains by human milk proteins |
| Q33618181 | In vitro evaluation of the role of antibodies against Helicobacter pylori in inhibiting adherence of the organism to gastric cells |
| Q34330198 | Inactivation of enveloped viruses in human bodily fluids by purified lipids |
| Q35458576 | Inhibition of S-fimbria-mediated adhesion to human ileostomy glycoproteins by a protein isolated from bovine colostrum |
| Q40752225 | Inhibition of enteropathogenic Escherichia coli (EPEC) adherence to HEp-2 cells by bovine colostrum and milk |
| Q37352254 | Interaction of early diet and the development of the immune system. |
| Q34383012 | Lacto-N-tetraose, fucosylation, and secretor status are highly variable in human milk oligosaccharides from women delivering preterm |
| Q34378895 | Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria |
| Q24806554 | Lactoferrin and free secretory component of human milk inhibit the adhesion of enteropathogenic Escherichia coli to HeLa cells |
| Q39864000 | Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli |
| Q36297326 | Lectin-based analysis of fucosylated glycoproteins of human skim milk during 47 days of lactation |
| Q44190396 | Maternal anemia induces changes in immunological and nutritional components of breast milk |
| Q35783582 | Maternal milk contains antimicrobial factors that protect young rabbits from enteropathogenic Escherichia coli infection |
| Q58848644 | Mechanisms of Colonisation and Colonisation Resistance of the Digestive Tract Part 1: Bacteria/host Interactions |
| Q52723039 | Mother's Milk: A Purposeful Contribution to the Development of the Infant Microbiota and Immunity. |
| Q38123163 | Multi-faceted functions of secretory IgA at mucosal surfaces |
| Q37333285 | Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans |
| Q33962816 | Oligosaccharides and glycoconjugates in human milk: their role in host defense |
| Q28376665 | Oligosaccharides in human milk during different phases of lactation |
| Q33565570 | Pharmacoeconomics of the therapy of diarrhoeal disease |
| Q35220308 | Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells |
| Q38874566 | Preparative scale purification of fucosyl-N-acetylglucosamine disaccharides and their evaluation as potential prebiotics and antiadhesins. |
| Q45159466 | Prevalent transfer of human colostral IgA antibody activity for the enteropathogenic Escherichia coli bundle-forming pilus structural repeating subunit A in neonates |
| Q37582714 | Protein-Linked Glycan Degradation in Infants Fed Human Milk |
| Q67835147 | Quantitative Determination of Complex Carbohydrates in Bovine Milk and in Milk-Based Infant Formulas |
| Q34375210 | Recent advances in understanding enteric pathogenic Escherichia coli. |
| Q33968246 | Recognition of enteropathogenic Escherichia coli virulence determinants by human colostrum and serum antibodies. |
| Q38323546 | Role of lactosyl glycan sequences in inhibiting enteropathogenic Escherichia coli attachment. |
| Q37065953 | Rotavirus-inhibitory activity in serial milk samples from Mexican women and rotavirus infections in their children during their first year of life |
| Q40379471 | Secretory immunoglobulin A obtained from pooled human colostrum and milk for oral passive immunization |
| Q37816402 | Sticky situation: localized adherence of enteropathogenic Escherichia coli to the small intestine epithelium |
| Q36222763 | Stopping bacterial adhesion: a novel approach to treating infections |
| Q34734717 | Structures and application of oligosaccharides in human milk |
| Q46631532 | Testing the efficacy of medium chain fatty acids against rabbit colibacillosis |
| Q47613860 | The Human Milk Glycome as a Defense Against Infectious Diseases: Rationale, Challenges, and Opportunities. |
| Q26860976 | The impact of the milk glycobiome on the neonate gut microbiota |
| Q37963071 | The influence of milk oligosaccharides on microbiota of infants: opportunities for formulas |
| Q33779090 | The role of the epidermal growth factor receptor in microbial infections of the gastrointestinal tract. |
| Q43045157 | Variation of human milk oligosaccharides in relation to milk groups and lactational periods |
| Q90448544 | Variations in porcine colostrum oligosaccharide composition between breeds and in association with sow maternal performance |
Search more.